Effectiveness of COVID-19 Vaccine (Covishield) among Health Care Workers of a Tertiary Cancer Care Hospital by Antibody Detection by Semi-Quantitative ELISA Method

Authors

  • Anand Shah Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India https://orcid.org/0000-0002-9217-9065
  • Parijat Goswami Microbiology Department, Sal Institute of Medical science, Ahmedabad, Gujarat, India
  • Ravi Patel Nootan Medical College and Research Centre, Vishnagar, Gujarat, India https://orcid.org/0000-0002-1901-9276
  • Shashank Pandya Surgical Oncology, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India
  • Rohini Patel Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India
  • Nirali Solanki Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India
  • Bhanuprasad Kotadia Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, Indi

DOI:

https://doi.org/10.37506/sccyp498

Keywords:

COVID vaccine, COVISHIELD, COVID Antibody, Health Care workers. Post Vaccination antibody

Abstract

Introduction: Currently there is no recommendation for testing post vaccination COVID antibody levels, however with repeated COVID waves it is important to evaluate post vaccination COVID antibody levels specifically among Health Care Workers.

Methods: This was an interventional study which was done with an objective of obtaining clinical history of COVID infection and vaccination status of the Health Care Worker (HCW) of the institute and to evaluate COVID 19 antibody levels by performing ELISA test. After taking consent, blood collection was done from 1399 health employees of The Gujarat Cancer & Research Institute. These samples were tested for post vaccination COVID antibody levels. The decrease in mean antibody levels among the partially and fully vaccinated groups was found to be significant by ANOVA at p value 0.05. Individuals with previous COVID infection history had better post COVID antibody levels after 6 months of last COVID dose and this was statistically significant by unpaired t test.

Conclusion: In this study we concluded that post vaccination COVID antibody level decreases consistently with time and number of COVID vaccine doses have no differences over long standing COVID antibody levels.

Author Biographies

  • Anand Shah, Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

    Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

  • Parijat Goswami, Microbiology Department, Sal Institute of Medical science, Ahmedabad, Gujarat, India

    Microbiology Department, Sal Institute of Medical science, Ahmedabad, Gujarat, India

  • Ravi Patel, Nootan Medical College and Research Centre, Vishnagar, Gujarat, India

    Nootan Medical College and Research Centre, Vishnagar, Gujarat, India

  • Shashank Pandya, Surgical Oncology, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

    Surgical Oncology, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

  • Rohini Patel, Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

    Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

  • Nirali Solanki, Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

    Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, India

  • Bhanuprasad Kotadia, Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, Indi

    Community Oncology Department, The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, Indi

References

Centers for Disease Control and Prevention. Coronavirus disease 2019. Available from: https://www.cdc.gov/dotw/covid-19/index.html [Accessed 9th September 2022]

World Health Organization. 14.9 million excess deaths were associated with the COVID-19 pandemic in 2020 and 2021. Available from: https://www.who.int/news/item/05-05-2022-14.9-million-excess-deaths-were-associated-with-the-covid-19-pandemic-in-2020-and-2021 [Accessed 9th September 2022]

World Health Organization. Coronavirus disease (COVID-19): Serology, antibodies and immunity. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-serology [Accessed 9th September 2022]

National Institutes of Health. Measuring protection after COVID-19 vaccination. Available from: https://www.nih.gov/news-events/nih-research-matters/measuring-protection-after-covid-19-vaccination [Accessed 9th September 2022]

Centers for Disease Control and Prevention. Interim guidelines for COVID-19 Antibody Testing. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html [Accessed 9th September 2022]

Serum Institute of India PVT. LTD. Coronavirus disease (COVID-19): Vaccines. Available from: https://www.seruminstitute.com/product_covishield.php [Accessed 9th September 2022]

Centers for Disease Control and Prevention. CDC COVID-19 Study shows mRNA vaccines reduce risk of infection by 91 percent for fully vaccinated people. Available from: https://www.cdc.gov/media/release/2021/p0607-mrna-reduce-risks.html [Accessed 9th September 2022]

Vassallo A, Shajahan S, Harris K, Hallam L, Hockham C, Womersley K, et al. Sex and Gender in COVID-19 Vaccine Research: Substantial Evidence Gaps Remain. Frontiers in Global Women's Health. 2021;2(761511):1-12. doi: 10.3389/fgwh.2021.761511

Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. The New England Journal of Medicine. 2021;385(24):e84(1-11). doi: 10.1056/NEJMoa2114583.

Choudhary HR, Parai D, Chandra Dash G, Kshatri JS, Mishra N, Choudhary PK, et al. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines. Frontiers in Medicine. 2021;8(778129):1-7. doi: 10.3389/fmed.2021.778129

Bates TA, McBride SK, Leier HC, Guzman G, Lyski ZL, Schoen D, et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Science Immunology. Report number: 7(68), 2022. doi: 10.1126/sciimmunol.abn8014

Murugesan M, Mathews P, Paul H, Karthik R, Mammen JJ, Rupali P. Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India. PLoS ONE. 2022;17(5):e0268797. Available from: https://doi.org/10.1371/journal.pone.0268797

Downloads

Published

2024-07-04

How to Cite

Effectiveness of COVID-19 Vaccine (Covishield) among Health Care Workers of a Tertiary Cancer Care Hospital by Antibody Detection by Semi-Quantitative ELISA Method. (2024). Indian Journal of Public Health Research & Development, 15(3), 215-219. https://doi.org/10.37506/sccyp498